Novartis, one of the world’s top pharmaceutical companies, has announced the rollout of its new Women in Pink campaign, which aims to raise awareness of breast cancer for a better quality of life for women across the UAE.
The campaign forms part of Novartis’ ongoing commitment to raise awareness and create solutions across the continuum of breast cancer care, and it encourages women in the UAE to become change-makers in their own health.
“Statista observes that in 2020 alone the UAE reported 1,030 new breast cancer cases among women, while the total number of new cancer cases in the general population currently sits at more than 4,800,” said Professor Humaid Al Shamsi, President of the Emirates Oncology Society. “That’s why it’s vital that we work together to improve public health education and awareness around prevention, early detection, diagnosis and treatment of breast cancer through initiatives such as the Women in Pink campaign.”
It will also empower women by providing them with the information to make the best choices for their treatment plan through partnerships with the Emirates Oncology Society and non-profit organisation, Friends of Cancer Patients.
“At Novartis, we’re on a mission to transform the lives of patients and connect people and communities to better quality care,” added Joy Khoury, Country Head Communications and Patient Engagement GCC at Novartis.
Click below to share this article